Mesa Laboratories (MLAB) EBT Margin (2010 - 2025)

Mesa Laboratories has disclosed EBT Margin across 16 years of filings, most recently posting 7.06% for Q4 2025.

• EBT Margin for Q4 2025 came in at 7.06%, up 1059.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 5.68% (up 11918.0% YoY), and the FY2025 annual result was 2.47%, up 12998.0% from the prior year.
• EBT Margin came in at 7.06% for Q4 2025 at Mesa Laboratories, up from 3.29% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 12.89% in Q1 2021 to a low of 467.42% in Q1 2024.
• The 5-year median for EBT Margin is 3.41% (2022), against an average of 20.61%.
• Across the five-year window, EBT Margin slumped 46693 bps in 2024 and jumped 46817 bps in 2025, its largest moves.
• Mesa Laboratories' EBT Margin stood at 4.28% in 2021, then surged by 182 bps to 3.53% in 2022, then gained by 3 bps to 3.64% in 2023, then sank by 197 bps to 3.53% in 2024, then soared by 300 bps to 7.06% in 2025.
• The last three EBT Margin figures came in at 7.06% (Q4 2025), 3.29% (Q3 2025), and 11.78% (Q2 2025), per Business Quant data.